Market Closed -
Hong Kong S.E.
01:38:20 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
2.45
HKD
|
+2.94%
|
|
+1.66%
|
-15.22%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
3,434
|
3,339
|
1,911
|
2,258
|
2,377
|
1,750
|
Enterprise Value (EV)
1 |
2,802
|
2,610
|
1,525
|
1,904
|
2,508
|
1,881
|
P/E ratio
|
5.97
x
|
5.78
x
|
3.34
x
|
5.18
x
|
4.79
x
|
3.92
x
|
Yield
|
1.39%
|
1.79%
|
3.13%
|
2.65%
|
3.02%
|
4.1%
|
Capitalization / Revenue
|
3.54
x
|
3.22
x
|
12.9
x
|
13.7
x
|
10.2
x
|
7.54
x
|
EV / Revenue
|
2.89
x
|
2.51
x
|
10.3
x
|
11.6
x
|
10.8
x
|
8.11
x
|
EV / EBITDA
|
66.7
x
|
79.1
x
|
34.5
x
|
90.6
x
|
47.3
x
|
48.8
x
|
EV / FCF
|
-18.4
x
|
11.4
x
|
-120
x
|
-6.16
x
|
-3.14
x
|
3.61
x
|
FCF Yield
|
-5.42%
|
8.77%
|
-0.83%
|
-16.2%
|
-31.8%
|
27.7%
|
Price to Book
|
0.53
x
|
0.5
x
|
0.27
x
|
0.3
x
|
0.27
x
|
0.21
x
|
Nbr of stocks (in thousands)
|
5,97,257
|
5,97,257
|
5,97,257
|
5,97,257
|
5,97,257
|
5,97,257
|
Reference price
2 |
5.750
|
5.590
|
3.200
|
3.780
|
3.980
|
2.930
|
Announcement Date
|
25/04/18
|
23/04/19
|
20/04/20
|
20/04/21
|
22/04/22
|
21/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
970.5
|
1,038
|
148.5
|
164.7
|
232.8
|
232
|
EBITDA
1 |
41.98
|
32.98
|
44.26
|
21.01
|
53.05
|
38.56
|
EBIT
1 |
40.69
|
31.91
|
43
|
19.74
|
51.51
|
37.11
|
Operating Margin
|
4.19%
|
3.07%
|
28.95%
|
11.99%
|
22.12%
|
16%
|
Earnings before Tax (EBT)
1 |
536.9
|
610.5
|
593.6
|
472.2
|
510
|
461.9
|
Net income
1 |
516.9
|
578.1
|
571.5
|
436.1
|
495.9
|
446.4
|
Net margin
|
53.26%
|
55.69%
|
384.73%
|
264.76%
|
212.99%
|
192.42%
|
EPS
2 |
0.9630
|
0.9679
|
0.9568
|
0.7301
|
0.8303
|
0.7474
|
Free Cash Flow
1 |
-152
|
228.8
|
-12.69
|
-308.9
|
-797.9
|
521.4
|
FCF margin
|
-15.66%
|
22.05%
|
-8.54%
|
-187.53%
|
-342.66%
|
224.76%
|
FCF Conversion (EBITDA)
|
-
|
693.89%
|
-
|
-
|
-
|
1,352.09%
|
FCF Conversion (Net income)
|
-
|
39.59%
|
-
|
-
|
-
|
116.81%
|
Dividend per Share
2 |
0.0800
|
0.1000
|
0.1000
|
0.1000
|
0.1200
|
0.1200
|
Announcement Date
|
25/04/18
|
23/04/19
|
20/04/20
|
20/04/21
|
22/04/22
|
21/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
131
|
131
|
Net Cash position
1 |
632
|
728
|
387
|
354
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
2.476
x
|
3.405
x
|
Free Cash Flow
1 |
-152
|
229
|
-12.7
|
-309
|
-798
|
521
|
ROE (net income / shareholders' equity)
|
9.15%
|
8.73%
|
8.3%
|
5.96%
|
6.08%
|
5.26%
|
ROA (Net income/ Total Assets)
|
0.37%
|
0.27%
|
0.36%
|
0.15%
|
0.36%
|
0.24%
|
Assets
1 |
1,38,058
|
2,10,751
|
1,59,544
|
2,84,822
|
1,39,267
|
1,83,011
|
Book Value Per Share
2 |
10.90
|
11.30
|
11.80
|
12.70
|
14.60
|
13.80
|
Cash Flow per Share
2 |
1.980
|
1.890
|
1.420
|
1.470
|
0.7800
|
0.9400
|
Capex
1 |
0.21
|
1.9
|
0.87
|
0.46
|
0.98
|
1.48
|
Capex / Sales
|
0.02%
|
0.18%
|
0.58%
|
0.28%
|
0.42%
|
0.64%
|
Announcement Date
|
25/04/18
|
23/04/19
|
20/04/20
|
20/04/21
|
22/04/22
|
21/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -15.22% | 187M | | +6.49% | 50.92B | | +1.35% | 48.11B | | +9.53% | 42.2B | | +6.55% | 39.71B | | +19.34% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -18.42% | 24.71B | | +6.89% | 21.99B |
Other Life & Health Insurance
|